Lifecore Biomedical to Present at Stephens Annual Investment Conference
12. November 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
07. November 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
04. November 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development...
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
04. Oktober 2024 07:30 ET
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 ---- Signed Multiple New Business Agreements with New and Existing Customers ---- More than Doubled Capacity with Installation of 5-Head...
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
04. Oktober 2024 07:20 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing...
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
03. Oktober 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
01. Oktober 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Multi-Million Dollar Development Agreement Establishes Lifecore as Lindy Biosciences’ Preferred CDMO Offers Lifecore Key Access Point into Manufacture and Fill/Finish of Next-Generation...
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
25. September 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
19. September 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
12. September 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...